Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Krisztina Melegh"'
Metasztatikus progresszió kezelése primer cutan és ocularis melanoma szinkrón előfordulását követően
Autor:
Eleonóra Imrédi, Vanda Plótár, Krisztina Schlachter, Gabriella Liszkay, Krisztina Melegh, Péter Szavcsur, Gitta Pánczél
Publikováno v:
Orvosi Hetilap. 159:642-647
Abstract: The incidence rates of cutaneous melanoma in non-Hispanic whites show an increasing tendency with age. While uveal melanoma in general is a rare disease, representing only 4% of all melanomas with an incidence rate of 0.6 per 100 000, it is
Autor:
András Gézsi, Gabriella Liszkay, Tímea Balatoni, Eszter Gorka, Krisztina Melegh, Peter Kovacs, Kata Czirbesz, Gitta Pánczél
Publikováno v:
Pathology & Oncology Research. 25:45-50
BRAF inhibitor vemurafenib achieved improved overall survival over chemotherapy and have been approved by the FDA and EMA for the treatment of BRAF-mutated metastatic melanoma. The aim of our retrospective analysis was to determine the efficacy and s
Autor:
Eleonóra, Imrédi, Vanda, Plótár, Péter, Szavcsur, Gitta, Pánczél, Krisztina, Melegh, Krisztina, Schlachter, Gabriella, Liszkay
Publikováno v:
Orvosi hetilap. 159(16)
The incidence rates of cutaneous melanoma in non-Hispanic whites show an increasing tendency with age. While uveal melanoma in general is a rare disease, representing only 4% of all melanomas with an incidence rate of 0.6 per 100 000, it is still the
Autor:
Péter, Kovács, Gitta, Pánczél, Krisztina, Melegh, Tímea, Balatoni, Edit, Pörneczy, Lenke, Lõrincz, Kata, Czirbesz, Eszter, Gorka, Gabriella, Liszkay
Publikováno v:
Magyar onkologia. 60(1)
Psychological problems may arise in connection with oncomedical treatments in three ways: 1. acute and/or 2. chronic ways, as well as 3. co-morbid psychiatric diseases that already exist must also be taken into account. Immunotherapies have the most